시장보고서
상품코드
1414459

세계 종양학 기반 In-Vivo CRO 시장 보고서(2024년)

Oncology Based In-Vivo CRO Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

종양학 기반 In-Vivo CRO 시장 규모는 최근 몇 년동안 강력하게 성장하고 있습니다. 2023년 12억 7,000만 달러로 평가되었고 2024년 13억 8,000만 달러에 달할 전망이며 복합 연간 성장률(CAGR) 8.4%로 확대될 것으로 예측됩니다. 이 기간의 성장은 암 치료제에 대한 관심 증가, 암 이환율 증가, 건강 관리 상황에서 맞춤형 의료로의 현저한 변화, 제약 업계 전체의 성장, 암과 관련된 특정 분자 마커나 세포 마커를 표적으로 하는 치료제에 대한 수요 증가 등 여러 요인에 기인하고 있습니다.

헬스케어 지출의 급증은 종양학 기반 In-Vivo CRO 시장의 확대를 촉진할 것으로 예상됩니다. 헬스케어 지출은 헬스케어 서비스와 관련된 비용을 포함하여 암 영역에서의 체외 CRO 서비스의 개발과 접근성에 크게 영향을 미칩니다. 특히 캐나다 건강정보연구소는 2022년 건강관리 지출은 전년 대비 0.8% 증가한 3,310억 달러에 달할 것으로 보고하고 있습니다. 이 지출의 급증이 암 영역의 체외 CRO 시장의 성장을 두드러지게 하고 있습니다.

2023년 종양학 기반 In-Vivo CRO 시장에서 가장 규모가 큰 지역은 북미였습니다. 북미는 예측 기간 동안 세계 종양 기반 생체내 CRO 시장 보고서에서 가장 급성장하는 지역이 될 전망입니다. 종양학 기반 In-Vivo CRO 시장 보고서의 대상 지역은 아시아태평양, 서유럽, 동유럽, 북미, 남미, 중동 및 아프리카입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 높은 인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계 시장 규모 실적과 성장(2018년-2023년)
  • 세계 시장 규모 예측과 성장(2023년-2028년, 2033년)

제6장 시장 세분화

  • 세계 종양학 기반 In-Vivo CRO 시장, 적응증별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 혈액암
  • 고형 종양
  • 기타 적응증
  • 세계 종양학 기반 In-Vivo CRO 시장, 모델별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 동계 모델
  • 이종이식편
  • 환자 유래 이종이식편(PDX)
  • 기타 모델
  • 세계 종양학 기반 In-Vivo CRO 시장, 용도별 세분화, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 병원
  • 재활센터

제7장 지역 및 국가 분석

  • 세계 종양학 기반 In-Vivo CRO 시장, 지역별, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)
  • 세계 종양학 기반 In-Vivo CRO 시장, 국가별, 분석 및 예측(2018년-2023년, 2023년-2028년, 2033년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 종양학 기반 In-Vivo CRO 시장 경쟁 구도
  • 종양학 기반 In-Vivo CRO 시장 기업 프로파일
    • Crown Bioscience
    • Charles River Laboratories International Inc.
    • Taconic Biosciences Inc.
    • The Jackson Laboratory
    • ICON plc

제31장 경쟁 벤치마킹

제32장 경쟁 대시보드

제33장 주요 인수합병(M&A)

제34장 미래 전망과 가능성 분석

제35장 부록

BJH 24.02.13

“Oncology Based In-Vivo CRO Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncology based in-vivo crow market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology based in-vivo crow? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The oncology based in-vivo crow market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Indication: Blood Cancer; Solid Tumors; Other Indications
  • 2) By Model: Syngeneic Model; Xenograft; Patient Derived Xenograft (PDX); Other Models
  • 3) By Application: Hospitals; Rehabilitation Centers
  • Companies Mentioned: Crown Bioscience; Charles River Laboratories International Inc.; Taconic Biosciences Inc.; The Jackson Laboratory; ICON plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

An oncology-focused in-vivo contract research organization (CRO) is a company contracted by another entity to conduct various stages of preclinical in-vivo studies for oncology drugs or devices. This includes designing, overseeing, monitoring, and analyzing preclinical in-vivo research involving living organisms such as animals, plants, or cells.

The primary areas of focus for oncology-based in-vivo CROs encompass blood cancer, solid tumors, and other related indications. Blood cancers originate from tissues responsible for blood formation, such as immune cells and bone marrow, including leukemia, lymphoma, and multiple myeloma. These CROs provide in-vivo testing services utilizing models such as blood cancer-based xenografts and others to expedite drug development research, aiding sponsors of drugs and devices in gaining market approval. Various models, including syngeneic, xenograft, patient-derived xenograft (PDX), and others, are employed by oncology-based in-vivo CROs and applied within hospital and rehabilitation settings.

The oncology based in-vivo CRO software market research report is one of a series of new reports from The Business Research Company that provides oncology based in-vivo CRO software market statistics, including oncology based in-vivo CRO software industry global market size, regional shares, competitors with a oncology based in-vivo CRO software market share, detailed oncology based in-vivo CRO software market segments, market trends and opportunities, and any further data you may need to thrive in the oncology based in-vivo CRO software industry. This oncology based in-vivo CRO software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncology based in-vivo cro market size has grown strongly in recent years. It will grow from $1.27 billion in 2023 to $1.38 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to several factors, including a heightened focus on oncology therapeutics, the rising incidence of cancer cases, a notable shift towards personalized medicine within the healthcare landscape, the overall growth of the pharmaceutical industry, and an increased demand for therapies targeting specific molecular or cellular markers associated with cancer.

The oncology based in-vivo cro market size is expected to see strong growth in the next few years. It will grow to $2 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. Anticipated growth in the forecasted period is expected to arise from emerging market prospects, a shift towards immuno-oncology therapies, an increase in the number of oncology clinical trials, the continued development of precision medicine and targeted therapies. Major trends projected for this period encompass advancements in regenerative medicine and cell therapies, a heightened demand for accelerated drug development processes, the integration of digitalization and data analytics in oncology research, a concentrated focus on understanding the tumor microenvironment, and an upsurge in the development and application of biologics and immunotherapies.

The anticipated surge in cancer cases is set to propel the expansion of the oncology-based in-vivo CRO market. Cancer, characterized by uncontrolled cell division and spread, necessitates innovative drugs and devices, prompting various preclinical and clinical trials for effective treatments. Oncology in-vivo CROs aid in these critical stages, conducting preclinical in-vivo studies to assess drugs or devices before human trials. The escalating cancer prevalence drives the demand for advanced treatments, consequently boosting the oncology-based in-vivo CRO market. As per the American Chemical Society, a 47% rise to 28.4 million cancer cases is forecasted by 2040 from 2020, reflecting the market's growth propelled by increasing cancer prevalence.

The upsurge in healthcare spending is expected to drive the expansion of the oncology-based in-vitro CRO market. Healthcare expenditure, encompassing costs related to healthcare services, significantly influences the development and accessibility of in-vitro CRO services within the oncology sector. Notably, the Canadian Institute for Health Information reported a rise in healthcare expenditure to $331 billion in 2022, indicating an 0.8% increase from the previous year. This surge in spending accentuates the market's growth within the oncology-based in-vitro CRO domain.

Major companies within the oncology-based in-vivo CRO market are keen on innovating to maintain their market positions. Crown Bioscience's launch of the 3D Ex Vivo Patient Tissue Platform in October 2021 exemplifies this trend. This platform, utilizing phenotypic 3D models of fresh patient tumors and high-content imaging analysis, enhances predictability for immuno-oncology drug candidates. It allows for relevant drug response analysis, aiding candidate selection and clinical program design.

Companies within this market segment are focusing on novel solutions such as CAR T-cell therapies to gain a competitive edge. For instance, Seattle Children's Hospital and Research Institute launched BrainChild Bio in May 2023, targeting CAR T-cell therapies for pediatric brain tumors such as diffuse intrinsic pontine gliomas (DIPG). This platform incorporates synthetic technologies to enhance CAR T-cell therapy for CNS malignancies, aiming to expand its applications to other challenging brain tumors such as glioblastoma and brain metastases. The pursuit of these innovative therapies signifies a strategic move to advance treatment options within the oncology-based in-vivo CRO market.

In March 2023, ClinChoice Medical Development, a US-based contract research organization (CRO) that provides research services to accelerate drug and device approvals, acquired Cromsource S.r.l. for an undisclosed amount. Through this acquisition, ClinChoice Medical Development expands its operational capabilities with additional delivery hubs to complement its existing network in Europe and the US. Data science technology offerings in several areas, including risk-based monitoring and decentralized clinical trials, are expanded through acquisition. Cromsource S.r.l. is an Italy-based contract research organization that provides full-research services to the pharmaceutical, biotechnology, and medical device industries.

Major companies operating in the oncology based in-vivo cro market report are Crown Bioscience, Charles River Laboratories International Inc., Taconic Biosciences Inc., The Jackson Laboratory, ICON plc., WuXi AppTec Inc., Eurofins Scientific SE, Labcorp Drug Development, Champion Oncology Inc., Xentech SAS, Thermo Fisher Scientific Inc., MI Bioresearch Inc., Clintec International Private Limited, Worldwide Clinical Trials Inc., Pharm-Olam LLC, Clinipace Clinical Research Private Limited, Covance Inc., Evotec SE, Living Tumor Laboratory, Oncodesign SA, Pharmaron Beijing Co. Ltd., Syngene International Limited, GenScript Biotech Corporation, Shanghai Medicilon Inc., Oncolys BioPharma Inc., Pharmalegacy Laboratories, Oncotest GmbH, Oncovision, Biocytogen LLC, Innovent Biologics Inc.

North America was the largest region in the oncology based in-vivo CRO market in 2023. North America is expected to be the fastest-growing region in the global oncology-based in-vivo CRO market report during the forecast period. The regions covered in the oncology based in-vivo cro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oncology based in-vivo cro market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oncology-based in-vivo CRO market includes revenues earned by entities by providing preclinical research services such as in-vivo testing via models such as Orthotopic tumor models, tumor passaging, tissue culture models, and others for oncology drugs and devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Oncology Based In-Vivo CRO Market Characteristics

3. Oncology Based In-Vivo CRO Market Trends And Strategies

4. Oncology Based In-Vivo CRO Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Oncology Based In-Vivo CRO Market Size and Growth

  • 5.1. Global Oncology Based In-Vivo CRO Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Oncology Based In-Vivo CRO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Oncology Based In-Vivo CRO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oncology Based In-Vivo CRO Market Segmentation

  • 6.1. Global Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Blood Cancer
  • Solid Tumors
  • Other Indications
  • 6.2. Global Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Syngeneic Model
  • Xenograft
  • Patient Derived Xenograft (PDX)
  • Other Models
  • 6.3. Global Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Rehabilitation Centers

7. Oncology Based In-Vivo CRO Market Regional And Country Analysis

  • 7.1. Global Oncology Based In-Vivo CRO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Oncology Based In-Vivo CRO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oncology Based In-Vivo CRO Market

  • 8.1. Asia-Pacific Oncology Based In-Vivo CRO Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oncology Based In-Vivo CRO Market

  • 9.1. China Oncology Based In-Vivo CRO Market Overview
  • 9.2. China Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oncology Based In-Vivo CRO Market

  • 10.1. India Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oncology Based In-Vivo CRO Market

  • 11.1. Japan Oncology Based In-Vivo CRO Market Overview
  • 11.2. Japan Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oncology Based In-Vivo CRO Market

  • 12.1. Australia Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oncology Based In-Vivo CRO Market

  • 13.1. Indonesia Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oncology Based In-Vivo CRO Market

  • 14.1. South Korea Oncology Based In-Vivo CRO Market Overview
  • 14.2. South Korea Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oncology Based In-Vivo CRO Market

  • 15.1. Western Europe Oncology Based In-Vivo CRO Market Overview
  • 15.2. Western Europe Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oncology Based In-Vivo CRO Market

  • 16.1. UK Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oncology Based In-Vivo CRO Market

  • 17.1. Germany Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oncology Based In-Vivo CRO Market

  • 18.1. France Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oncology Based In-Vivo CRO Market

  • 19.1. Italy Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oncology Based In-Vivo CRO Market

  • 20.1. Spain Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oncology Based In-Vivo CRO Market

  • 21.1. Eastern Europe Oncology Based In-Vivo CRO Market Overview
  • 21.2. Eastern Europe Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oncology Based In-Vivo CRO Market

  • 22.1. Russia Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oncology Based In-Vivo CRO Market

  • 23.1. North America Oncology Based In-Vivo CRO Market Overview
  • 23.2. North America Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oncology Based In-Vivo CRO Market

  • 24.1. USA Oncology Based In-Vivo CRO Market Overview
  • 24.2. USA Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oncology Based In-Vivo CRO Market

  • 25.1. Canada Oncology Based In-Vivo CRO Market Overview
  • 25.2. Canada Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oncology Based In-Vivo CRO Market

  • 26.1. South America Oncology Based In-Vivo CRO Market Overview
  • 26.2. South America Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oncology Based In-Vivo CRO Market

  • 27.1. Brazil Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oncology Based In-Vivo CRO Market

  • 28.1. Middle East Oncology Based In-Vivo CRO Market Overview
  • 28.2. Middle East Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oncology Based In-Vivo CRO Market

  • 29.1. Africa Oncology Based In-Vivo CRO Market Overview
  • 29.2. Africa Oncology Based In-Vivo CRO Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Oncology Based In-Vivo CRO Market, Segmentation By Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Oncology Based In-Vivo CRO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oncology Based In-Vivo CRO Market Competitive Landscape And Company Profiles

  • 30.1. Oncology Based In-Vivo CRO Market Competitive Landscape
  • 30.2. Oncology Based In-Vivo CRO Market Company Profiles
    • 30.2.1. Crown Bioscience
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Charles River Laboratories International Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Taconic Biosciences Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. The Jackson Laboratory
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. ICON plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Oncology Based In-Vivo CRO Market Competitive Benchmarking

32. Global Oncology Based In-Vivo CRO Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Oncology Based In-Vivo CRO Market

34. Oncology Based In-Vivo CRO Market Future Outlook and Potential Analysis

  • 34.1 Oncology Based In-Vivo CRO Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Oncology Based In-Vivo CRO Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Oncology Based In-Vivo CRO Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제